Johnson & Johnson
JNJ · NYSE
12/29/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $345,062,382 | $397,100,790 | $461,691,910 | $449,737,043 |
| - Cash | $24,105,000 | $21,859,000 | $12,889,000 | $14,487,000 |
| + Debt | $37,834,000 | $29,332,000 | $39,642,000 | $33,751,000 |
| Enterprise Value | $358,791,382 | $404,573,790 | $488,444,910 | $469,001,043 |
| Revenue | $88,821,000 | $85,159,000 | $79,990,000 | $78,740,000 |
| % Growth | 4.3% | 6.5% | 1.6% | – |
| Gross Profit | $61,350,000 | $58,606,000 | $55,394,000 | $55,338,000 |
| % Margin | 69.1% | 68.8% | 69.3% | 70.3% |
| EBITDA | $24,781,000 | $23,320,000 | $26,605,000 | $26,751,000 |
| % Margin | 27.9% | 27.4% | 33.3% | 34% |
| Net Income | $14,066,000 | $35,153,000 | $17,941,000 | $20,878,000 |
| % Margin | 15.8% | 41.3% | 22.4% | 26.5% |
| EPS Diluted | 5.79 | 13.72 | 6.73 | 7.81 |
| % Growth | -57.8% | 103.9% | -13.8% | – |
| Operating Cash Flow | $24,266,000 | $22,791,000 | $21,194,000 | $23,410,000 |
| Capital Expenditures | -$4,424,000 | -$4,543,000 | -$4,009,000 | -$3,652,000 |
| Free Cash Flow | $19,842,000 | $18,248,000 | $17,185,000 | $19,758,000 |